Speaker Profile
M.D., Ph.D., Founder & CSO, Genomate Health
Biography
Istvan Petak has spent more than 25 years exploring how the molecular biology of cancer can guide treatment. His research began at Semmelweis University and St. Jude Children’s Research Hospital, investigating the biological mechanisms that influence individual drug sensitivity.
He helped pioneer molecular companion diagnostics for EGFR in 2003 and the application of next-generation sequencing to precision oncology in 2008. He is the lead inventor of Genomate’s computational reasoning method, developed to translate complex molecular profiles into personalized therapeutic recommendations.
His work now connects two challenges: helping physicians identify treatments for individual patients and helping drug developers identify the patients most likely to benefit from a therapy. Across both, his focus remains on bringing scientific knowledge into decisions that matter for people with cancer.
Talk
Genomate: Connecting Cancer Patients, Drugs, and Evidence
Which drug for this patient, and which patients for this drug? Genomate Health applies computational reasoning to both questions. This presentation explores its clinical evidence, commercial adoption, and applications in treatment selection and drug rescue, showing how one platform connects precision cancer care with therapeutic development.
AI for Clinical Decision Support Systems Showcase:
Genomate Health
Genomate Health develops computational infrastructure for precision oncology, grounded in over 25 years of molecular oncology research. Its patented Genomate® platform translates molecular data and scientific evidence into insights supporting personalized treatment selection, drug development, and drug rescue.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
